Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoablation with Sintilimab and Lenvatinib in Liver Metastasis
NCT05098847Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Oct 2021
- Primary completion
- Oct 2025
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab, lenvatinib in liver metastasis, sponsored by Fudan University. Started Oct 2021; status: recruiting.
02
Drugs
sintilimablenvatinib
03
Conditions
liver metastasis
Beyond the preview
Go deeper on NCT05098847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05098847.